SCHEMBL17985448

SCHEMBL17985448

CC(C)(C)OC(=O)NCC1CC1c1cc(Cl)ccc1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.40
HTR2C P28335 5/20 0.40
ALDH1A1 P00352 2/20 0.40
HPGD P15428 2/20 0.40
HTT P42858 2/20 0.40
KDM4E B2RXH2 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
ACACB O00763 1/20 0.39
ACACA Q13085 1/20 0.39
TP53 P04637 1/20 0.39
GLA P06280 1/20 0.39
MAPT P10636 1/20 0.39
XBP1 P17861 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HSD17B10 Q99714 1/20 0.39
DRD2 P14416 1/20 0.39
HTR2B P41595 4/20 0.39
HTR2A P28223 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23544489 1.00 IDO1 (0.40) IDO1HTR2CALDH1A1HPGDHTT
SCHEMBL17986628 0.88 SERPINE1 (0.39) IDO1HTR2CALDH1A1HPGDHTT
SCHEMBL14797777 0.88 NQO2 (0.41) HTR2CALDH1A1HPGDKDM4EACACB
SCHEMBL21335602 0.88 SERPINE1 (0.39) IDO1HTR2CALDH1A1HPGDHTT
SCHEMBL14797776 0.88 NQO2 (0.41) HTR2CALDH1A1HPGDKDM4EACACB
SCHEMBL14802708 0.87 SERPINE1 (0.38) HTR2CALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL14802654 0.86 HTR2C (0.44) HTR2CHTR2BHTR2ASERPINE1
SCHEMBL17986378 0.84 HTR2C (0.60) HTR2CHTR2BHTR2A
SCHEMBL17986302 0.84 HTR2C (0.43) HTR2CHTR2BHTR2A
SCHEMBL17985446 0.83 HTR2A (0.50) IDO1HTR2CACACBACACADRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3250549-B1 CYCLOPROPYLMETHANAMINES AS SELECTIVE 5-HT(2C) RECEPTOR AGONISTS UNIV ILLINOIS (US) 2021-06-23 EP disclosed
US-10407381-B2 Cyclopropylmethanamines as selective 5-HT(2C) receptor agonists THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2019-09-10 US disclosed
WO-2016123164-A1 CYCLOPROPYLMETHANAMINES AS SELECTIVE 5-HT(2C) RECEPTOR AGONISTS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2016-08-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10407381-B2 Cyclopropylmethanamines as selective 5-HT(2C) receptor agonists HTR2C, HTR2A, HTR1A IDO1 375/4885HTR2C 1/4885ALDH1A1 1876/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.